Affymetrix (AFFX)
Affymetrix R&D Expense: 13.33M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AFFX R&D Expense Rankings
| Overall | 28th percentile | 1268 of 1764 |
| Sector | 36th percentile | 407 of 646 in Technology |
| Industry | 31st percentile | 31 of 45 in Scientific & Technical Instruments |
AFFX R&D Expense Range, Past 5 Years
| Minimum | 13.33M | Mar 2012 |
| Maximum | 25.38M | Dec 2008 |
| Average | 18.01M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these AFFX related companies
AFFX News
Affymetrix (AFFX), ScreenCell Enter CTC Collection Buffer Distribution Agreement
May 17, 7:33AM Street Insider
May 17, 7:33AM Street Insider
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology
May 17, 7:30AM Business Wire
May 17, 7:30AM Business Wire
Just noticed, still open RT @biotechtraderHB $AFFX: ~ 10,000 NOV 5 strike Calls trade...
about 18 days ago by illinijill
about 18 days ago by illinijill
$AFFX Mentioned more than normal on StockTwits - Currently at 16 x average daily social activity
about 20 days ago by TradeIdeasQuant
about 20 days ago by TradeIdeasQuant
EBR: Watchlist/worksheet/4 Trading Ideas: $DF $EQR $ENOC $AFFX $ELGX $OFC http://stks.co/3hIf
about 20 days ago by TheEquitiesRoom
about 20 days ago by TheEquitiesRoom
Watchlist 5/7.Careful tday but following charts look ready for a small run.$KGJI,$AFFX,$GEOY,$NAVG,$PDLI,$VNET.Look for intraday weakness.
about 20 days ago by traderNC
about 20 days ago by traderNC
$AFFX http://stks.co/3gZm Like it long on a break of 4.74 There is plenty of accumulation on this daily chart.
about 22 days ago by ACInvestorBlog
about 22 days ago by ACInvestorBlog
$AFFX is 6.0% up since open on unusual high volume and 6.3% up since close.
about 23 days ago by TradeBot
about 23 days ago by TradeBot
Listen to $AFFX Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3f4x
about 24 days ago by earningscast
about 24 days ago by earningscast
Affymetrix, Inc. (AFFX) Posts Narrower than Expected Q1 Loss of 6c/Share
May 03, 4:10PM Street Insider
May 03, 4:10PM Street Insider
Affymetrix to Host Conference Call on May 3, 2012 to Announce First Quarter 2012 Operating Results
Apr 17, 4:18PM Business Wire
Apr 17, 4:18PM Business Wire
Affymetrix (AFFX), Lineagen to Collaborate on Next-Gen FirstStepDx for DD, ASD Evaluation
Mar 28, 7:37AM Street Insider
Mar 28, 7:37AM Street Insider
Listen to $AFFX Q4 2011 earnings call (EPS -0.21 vs est -0.07) - live at 05:00 PM, ondemand after - http://stks.co/2JZU
about 109 days ago by earningscast
about 109 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AFFX | 4.96 | +0.03 | +0.61% | 349.43M |
| AFFM | 0.4502 | -0.10 | -18.10% | 6.938M |
| AGO | 12.23 | -0.11 | -0.89% | 2.233B |
| AGNC | 32.22 | +0.09 | +0.28% | 9.666B |
| AGN | 90.53 | +0.04 | +0.04% | 27.59B |
| AGMA | 18.51 | +0.00 | +0.00% | |
| AGM | 24.44 | +0.11 | +0.45% | 253.20M |
| AGII | 28.82 | +0.77 | +2.75% | 753.64M |
| AGG | 110.92 | +0.17 | +0.15% | |
| AGEND | 5.20 | +0.06 | +1.17% |
